Alexandra Mancini
2021
In 2021, Alexandra Mancini earned a total compensation of $406.2K as Senior VP, Clinical & Regulatory Affairs at InMed Pharmaceuticals, a 32% increase compared to previous year.
Compensation breakdown
Bonus | $84,788 |
---|---|
Option Awards | $69,083 |
Salary | $252,346 |
Total | $406,217 |
Mancini received $252.3K in salary, accounting for 62% of the total pay in 2021.
Mancini also received $84.8K in bonus and $69.1K in option awards.
Rankings
In 2021, Alexandra Mancini's compensation ranked 11,129th out of 12,406 executives tracked by ExecPay. In other words, Mancini earned more than 10.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 11,129 | 10th |
Manufacturing | 4,908 | 11th |
Chemicals And Allied Products | 2,186 | 8th |
Drugs | 1,945 | 7th |
Pharmaceutical Preparations | 1,438 | 6th |
Mancini's colleagues
We found three more compensation records of executives who worked with Alexandra Mancini at InMed Pharmaceuticals in 2021.
News
InMed Pharmaceuticals CEO Eric Adams' 2024 pay rises 13% to $415K
October 28, 2024
InMed Pharmaceuticals CEO Eric Adams' 2023 pay falls 22% to $368K
October 27, 2023
InMed Pharmaceuticals CEO Eric Adams' 2022 pay falls 36% to $468K
October 28, 2022
InMed Pharmaceuticals CEO Eric Adams' 2021 pay jumps 73% to $735K
October 28, 2021